Intravesical oncolytic viral therapy using attenuated, replication-competent herpes simplex viruses G207 and Nv1020 is effective in the treatment of bladder cancer in an orthotopic syngeneic model

FASEB J. 2001 May;15(7):1306-8. doi: 10.1096/fj.00-0533fje.

Authors

P J Cozzi¹, S Malhotra, P McAuliffe, D A Kooby, H J Federoff, B Huryk, P Johnson, P T Scardino, W D Heston, Y Fong

Affiliation

¹ The George M O'Brien Urology Research Center, Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

PMID: 11344122
DOI: 10.1096/fj.00-0533fje

No abstract available

MeSH terms

Animals
Biological Therapy / methods*
Disease Models, Animal
Humans
Mice
Simplexvirus / genetics
Simplexvirus / pathogenicity
Simplexvirus / physiology*
Tumor Cells, Cultured
Urinary Bladder Neoplasms / therapy*
Urinary Bladder Neoplasms / virology*
Virus Replication